Magda Michna
Fortuna: 1 M $ al 30/09/2026
Fortuna: 1 M $ al 30/09/2026
Magda Michna is currently Chief Development Officer at STAAR Surgical Co., starting in 2025.
Formerly, Dr. Michna was Head-Chief Global Clinical & Medical Officer at AcuFocus, Inc. from 2018 to 2023 and Chief Clinical Officer at Presbia PLC from 2012 to 2017.
Education includes undergraduate and doctorate degrees from the University of Melbourne.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
STAAR SURGICAL COMPANY 0,09 % | 14/08/2026 | 46.026 ( 0,09 % ) | 1 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| STAAR SURGICAL COMPANY | Corporate Officer/Principal | 18/03/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
AcuFocus, Inc.
AcuFocus, Inc. Medical SpecialtiesHealth Technology Manufactures and wholesales ophthalmic medical device | Director Técnico/Científico/I+D | 01/01/2023 |
| PRESBIA PLC | Director Técnico/Científico/I+D | 02/01/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
STAAR Surgical Co.
STAAR Surgical Co. Medical SpecialtiesHealth Technology Designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver lenses into the eye | Health Technology |
AcuFocus, Inc.
AcuFocus, Inc. Medical SpecialtiesHealth Technology Manufactures and wholesales ophthalmic medical device | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Presbia PLC
Presbia PLC Medical SpecialtiesHealth Technology Develops, manufactures and commercializes ophthalmic medical devices | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.